Printed from https://ideas.repec.org/s/eme/aheszz.html
Content
2017
- 3-29 Birth Spacing and Educational Outcomes
In: Human Capital and Health Behavior
by Elaine L. Hill & David J. G. Slusky - 33-83 Individual Investments in Education and Health: Policy Responses and Interactions☆
In: Human Capital and Health Behavior
by Jared C. Carbone & Snorre Kverndokk - 85-107 Causal Effects of Maternal Schooling on Child Immunization in India
In: Human Capital and Health Behavior
by Prabal K. De - 111-142 Effects of Maternal Work Incentives on Teen Drug Arrests
In: Human Capital and Health Behavior
by Hope Corman & Dhaval M. Dave & Ariel Kalil & Nancy E. Reichman - 143-179 Behavioral Welfare Economics and FDA Tobacco Regulations
In: Human Capital and Health Behavior
by Philip DeCicca & Donald Kenkel & Feng Liu & Hua Wang - 183-206 Educational Heterogeneity in the Association between Smoking Cessation and Health Information
In: Human Capital and Health Behavior
by Dean R. Lillard - 207-242 The Effect of Education on Health Behavior after Screening for Colorectal Cancer
In: Human Capital and Health Behavior
by Eline Aas & Tor Iversen & Geir Hoff - 245-277 Unemployment Insurance and Physical Activity
In: Human Capital and Health Behavior
by Jonathan Cylus
2014
- 1-92 Altruism, Efficiency, and Health in the Family
In: Preference Measurement in Health
by Mark Dickie & Matthew J. Salois - 93-121 Adolescent Girls’ Preferences for HPV Vaccines: A Discrete Choice Experiment
In: Preference Measurement in Health
by Derek S. Brown & Christine Poulos & F. Reed Johnson & Linda Chamiec-Case & Mark L. Messonnier - 123-140 Gender Differences in Risk Attitudes
In: Preference Measurement in Health
by L. Warshawsky-Livne & L. Novack & A. B. Rosen & S. M. Downs & J. Shkolnik-Inbar & J. S. Pliskin - 141-160 Mutual Altruism: Evidence from Alzheimer Patients and Their Spouse Caregivers
In: Preference Measurement in Health
by Markus König & Christian Pfarr & Peter Zweifel - 161-202 How Should the Health Benefits of Food Safety Programs Be Measured?
In: Preference Measurement in Health
by V. Kerry Smith & Carol Mansfield & Aaron Strong - 203-295 Pesticides and Health: A Review of Evidence on Health Effects, Valuation of Risks, and Benefit-Cost Analysis
In: Preference Measurement in Health
by Damian Tago & Henrik Andersson & Nicolas Treich
2012
- 1-33 Aspects of Research and Development Contract Terms in the Bio/Pharmaceutical Sector
In: The Economics of Medical Technology
by Tannista Banerjee - 35-71 Effects of Regulation on Drug Launch and Pricing in Interdependent Markets
In: The Economics of Medical Technology
by Patricia M. Danzon & Andrew J. Epstein - 73-101 The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans: Evidence from the 2004 National Nursing Home Survey
In: The Economics of Medical Technology
by Frank R. Lichtenberg - 103-121 Comparative Effectiveness Research, Technological Abandonment, and Health Care Spending
In: The Economics of Medical Technology
by David H. Howard & Yu-Chu Shen - 123-148 How do Initial Signals of Quality Influence the Diffusion of New Medical Products? The Case of New Cancer Drug Treatments
In: The Economics of Medical Technology
by Rena M. Conti & Arielle Bernstein & David O. Meltzer - 149-175 Technology Diffusion and Substitution of Medical Innovations
In: The Economics of Medical Technology
by Victoria Serra-Sastre & Alistair McGuire - 177-198 Health Insurance and Hospital Technology Adoption
In: The Economics of Medical Technology
by Seth Freedman
2010
- 3-27 Pharmaceutical policies in European countries
In: Pharmaceutical Markets and Insurance Worldwide
by Pedro Pita Barros - 29-50 International experience with comparative effectiveness research: Case studies from England/Wales and Germany
In: Pharmaceutical Markets and Insurance Worldwide
by John F.P. Bridges & Joshua P. Cohen & Peter G. Grist & Axel C. Mühlbacher - 53-76 Pharmaceutical policy in the Netherlands: From price regulation towards managed competition
In: Pharmaceutical Markets and Insurance Worldwide
by Lieke H.H.M. Boonen & Stéphanie A. van der Geest & Frederik T. Schut & Marco Varkevisser - 77-101 Impact of pharmaceutical regulation and policies on health system performance goals in Israel
In: Pharmaceutical Markets and Insurance Worldwide
by Philip Sax & Amir Shmueli - 103-122 Global budgets and provider incentives: Hospitals’ drug expenditures in Taiwan
In: Pharmaceutical Markets and Insurance Worldwide
by Shin-Yi Chou & Mary E. Deily & Hsien-Ming Lien & Jing Hua Zhang - 123-147 Medicare Part D turns four: Trends in plan design, enrollment, and the impact of the program on beneficiaries
In: Pharmaceutical Markets and Insurance Worldwide
by Jack Hoadley & Kosali Simon - 151-173 Does prescription drug adherence reduce hospitalizations and costs? The case of diabetes
In: Pharmaceutical Markets and Insurance Worldwide
by William E. Encinosa & Didem Bernard & Avi Dor - 175-193 cost sharing, benefit design, and adherence: The case of multiple sclerosis
In: Pharmaceutical Markets and Insurance Worldwide
by Avi Dor & Maureen J. Lage & Marcy L. Tarrants & Jane Castelli-Haley - 195-219 Generic utilization and cost-sharing for prescription drugs
In: Pharmaceutical Markets and Insurance Worldwide
by Teresa Bernard Gibson & Catherine G. McLaughlin & Dean G. Smith - 221-231 Drug prices, out-of-pocket payments, and insurer costs: How do payers vary?
In: Pharmaceutical Markets and Insurance Worldwide
by Jie Chen & John A. Rizzo - 233-272 Adverse selection and the effect of health insurance on utilization of prescribed medicine among patients with chronic conditions
In: Pharmaceutical Markets and Insurance Worldwide
by Yuriy Pylypchuk - 273-292 The effect of drug vintage on survival: Micro evidence from Puerto Rico's Medicaid program
In: Pharmaceutical Markets and Insurance Worldwide
by Frank R. Lichtenberg - 295-316 Retail pharmacy market structure and insurer-independent pharmacy bargaining in the medicare part D era
In: Pharmaceutical Markets and Insurance Worldwide
by Yang Xie & John M. Brooks & Julie M. Urmie & William R. Doucette - 317-344 Patents, innovation, and the welfare effects of Medicare Part D
In: Pharmaceutical Markets and Insurance Worldwide
by Adam Gailey & Darius Lakdawalla & Neeraj Sood
2009
- 3-22 The double burden of disease in developing countries: The Mexican experience
In: Innovations in Health System Finance in Developing and Transitional Economies
by Cristina Gutiérrez-Delgado & Veronica Guajardo-Barrón - 23-53 Protecting pro-poor health services during financial crises: Lessons from experience
In: Innovations in Health System Finance in Developing and Transitional Economies
by Pablo Gottret & Vaibhav Gupta & Susan Sparkes & Ajay Tandon & Valerie Moran & Peter Berman - 57-81 The equity impact of the universal coverage policy: Lessons from Thailand
In: Innovations in Health System Finance in Developing and Transitional Economies
by Phusit Prakongsai & Supon Limwattananon & Viroj Tangcharoensathien - 83-106 Social health insurance and labor market outcomes: Evidence from Central and Eastern Europe, and Central Asia
In: Innovations in Health System Finance in Developing and Transitional Economies
by Adam Wagstaff & Rodrigo Moreno-Serra - 107-132 Trust in the context of community-based health insurance schemes in Cambodia: Villagers’ trust in health insurers
In: Innovations in Health System Finance in Developing and Transitional Economies
by Sachiko Ozawa & Damian G. Walker - 133-156 Methodological challenges in evaluating health care financing equity in data-poor contexts: Lessons from Ghana, South Africa and Tanzania
In: Innovations in Health System Finance in Developing and Transitional Economies
by Josephine Borghi & John Ataguba & Gemini Mtei & James Akazili & Filip Meheus & Clas Rehnberg & Di McIntyre - 159-196 The role of risk equalization in moving from voluntary private health insurance to mandatory coverage: the experience in South Africa
In: Innovations in Health System Finance in Developing and Transitional Economies
by Heather McLeod & Pieter Grobler - 197-218 Purchasing health care in China: Experiences, Opportunities and challenges
In: Innovations in Health System Finance in Developing and Transitional Economies
by Winnie Yip & Kara Hanson - 221-249 The impact of Nepal's national incentive programme to promote safe delivery in the district of Makwanpur
In: Innovations in Health System Finance in Developing and Transitional Economies
by T. Powell-Jackson & B.D. Neupane & S. Tiwari & K. Tumbahangphe & D. Manandhar & A.M. Costello - 251-288 Service- and population-based exemptions: Are these the way forward for equity and efficiency in health financing in low-income countries?
In: Innovations in Health System Finance in Developing and Transitional Economies
by Sophie Witter - 291-312 From scheme to system: social health insurance funds and the transformation of health financing in Kyrgyzstan and Moldova
In: Innovations in Health System Finance in Developing and Transitional Economies
by Joseph Kutzin & Melitta Jakab & Sergey Shishkin - 313-338 Reforming “developing” health systems: Tanzania, Mexico, and the United States
In: Innovations in Health System Finance in Developing and Transitional Economies
by Dov Chernichovsky & Gabriel Martinez & Nelly Aguilera
2008
- 1-1 Introduction
In: Beyond Health Insurance: Public Policy to Improve Health
by Lorens Helmchen & Robert Kaestner & Anthony Lo Sasso - 1-24 Quantifying national spending on wellness and prevention
In: Beyond Health Insurance: Public Policy to Improve Health
by George Miller & Charles Roehrig & Paul Hughes-Cromwick & Craig Lake - 1-29 Three studies on the neuroeconomics of decision-making when payoffs are real and negative
In: Neuroeconomics
by Gregory S. Berns & C. Monica Capra & Sara Moore & Charles Noussair - 25-41 Achieving the healthy people 2010 goal of elimination of health disparities: What will it take?
In: Beyond Health Insurance: Public Policy to Improve Health
by Kevin Fiscella - 31-53 Emotion, decision-making and the brain
In: Neuroeconomics
by Luke J. Chang & Alan G. Sanfey - 43-69 Influence, information overload, and information technology in health care
In: Beyond Health Insurance: Public Policy to Improve Health
by James B. Rebitzer & Mari Rege & Christopher Shepard - 55-84 Anxiety and decision-making: Toward a neuroeconomics perspective
In: Neuroeconomics
by Andrei C. Miu & Mircea Miclea & Daniel Houser - 71-94 Health disparities and direct-to-consumer advertising of pharmaceutical products
In: Beyond Health Insurance: Public Policy to Improve Health
by Rosemary J. Avery & Donald Kenkel & Dean R. Lillard & Alan Mathios & Hua Wang - 85-97 The potential role of regret in the physician–patient relationship: Insights from neuroeconomics
In: Neuroeconomics
by Giorgio Coricelli - 95-117 Pharmaceutical innovation and the longevity of Australians: A first look
In: Beyond Health Insurance: Public Policy to Improve Health
by Frank R. Lichtenberg & Gautier Duflos - 99-124 How primates (including us!) respond to inequity
In: Neuroeconomics
by Sarah F. Brosnan - 119-143 Spillover effects of prescription drug withdrawals
In: Beyond Health Insurance: Public Policy to Improve Health
by John Cawley & John A. Rizzo - 125-159 On the nature, modeling, and neural bases of social ties
In: Neuroeconomics
by Frans van Winden & Mirre Stallen & K. Richard Ridderinkhof - 145-172 The psychology of nutrition messages
In: Beyond Health Insurance: Public Policy to Improve Health
by Heather Schofield & Sendhil Mullainathan - 161-178 Emotion expression, decision-making and well-being
In: Neuroeconomics
by Erte Xiao - 173-189 Evaluation criteria for report cards of healthcare providers
In: Beyond Health Insurance: Public Policy to Improve Health
by Jesse D. Schold - 179-201 Source preference and ambiguity aversion: models and evidence from behavioral and neuroimaging experiments
In: Neuroeconomics
by Soo Hong Chew & King King Li & Robin Chark & Songfa Zhong - 191-206 Evaluating the value of genomic diagnostics: Implications for clinical practice and public policy
In: Beyond Health Insurance: Public Policy to Improve Health
by Amalia M. Issa - 203-225 Neuroeconomics of decision-making in the aging brain: the example of long-term care
In: Neuroeconomics
by Ming Hsu & Hung-Tai Lin & Paul E. McNamara - 227-270 Health economic choices in old age: Interdisciplinary perspectives on economic decisions and the aging mind
In: Neuroeconomics
by Lisbeth Nielsen & John W.R. Phillips - 271-288 Child health disparities, socio-economic status, and school enrollment decisions: Evidence from German elementary school entrance exams
In: Neuroeconomics
by Martin Salm & Daniel Schunk - 289-309 Temporal discounting as a measure of executive function: Insights from the competing neuro-behavioral decision system hypothesis of addiction
In: Neuroeconomics
by Warren K. Bickel & Richard Yi - 311-327 Expectations mediate objective physiological placebo effects
In: Neuroeconomics
by Anup Malani & Daniel Houser
2007
- 3-12 Chapter 1 Productivity in Hospital Industry
In: Evaluating Hospital Policy and Performance: Contributions from Hospital Policy and Productivity Research
by Jos L.T. Blank & Vivian G. Valdmanis - 13-32 Chapter 2 Measuring and Decomposing Productivity Change: The Basics
In: Evaluating Hospital Policy and Performance: Contributions from Hospital Policy and Productivity Research
by Bert M. Balk - 33-42 Chapter 3 Measuring Hospital Services
In: Evaluating Hospital Policy and Performance: Contributions from Hospital Policy and Productivity Research
by James F. Burgess & Jr. - 45-61 Chapter 4 Hospital Consolidation and Integration Activity in the United States
In: Evaluating Hospital Policy and Performance: Contributions from Hospital Policy and Productivity Research
by Gloria J. Bazzoli - 63-88 Chapter 5 Organizational Structure and Productive Efficiency of Non-Profit Hospitals
In: Evaluating Hospital Policy and Performance: Contributions from Hospital Policy and Productivity Research
by Ila Semenick Alam & Gerald Granderson - 89-109 Chapter 6 Innovations and Productivity: An Empirical Investigation in Dutch Hospital Industry
In: Evaluating Hospital Policy and Performance: Contributions from Hospital Policy and Productivity Research
by Jos L.T. Blank - 113-138 Chapter 7 The Impact of Ownership on the Cost-Efficiency of U.S. Hospitals
In: Evaluating Hospital Policy and Performance: Contributions from Hospital Policy and Productivity Research
by Ryan L. Mutter & Michael D. Rosko - 139-156 Chapter 8 Competition and Market Concentration
In: Evaluating Hospital Policy and Performance: Contributions from Hospital Policy and Productivity Research
by Nazmi Sari - 157-176 Chapter 9 Efficiency and Productivity Changes in Large Urban Hospitals 1994–2002: Ownership, Markets, and the Uninsured
In: Evaluating Hospital Policy and Performance: Contributions from Hospital Policy and Productivity Research
by Gary D. Ferrier & Vivian G. Valdmanis - 179-190 Chapter 10 Benchmarking Finnish Hospitals
In: Evaluating Hospital Policy and Performance: Contributions from Hospital Policy and Productivity Research
by Miika Linna & Unto Häkkinen - 191-208 Chapter 11 Efficiency in Government-Funded Health Care Services: The Use of Non-Health Sector Mechanisms to Encourage Efficiency
In: Evaluating Hospital Policy and Performance: Contributions from Hospital Policy and Productivity Research
by Abby L. Bloom - 209-228 Chapter 12 Evaluating Health Care Efficiency
In: Evaluating Hospital Policy and Performance: Contributions from Hospital Policy and Productivity Research
by Rolf Färe & Shawna Grosskopf & Mats Lundström & Pontus Roos - 231-240 Chapter 13 Efficiency in Hospital Industry: Summary and Conclusions
In: Evaluating Hospital Policy and Performance: Contributions from Hospital Policy and Productivity Research
by Jos L.T. Blank & Vivian G. Valdmanis
2006
- 3-21 Endogenous Food Quality and Bodyweight Trend
In: The Economics of Obesity
by Liqun Liu & Andrew J. Rettenmaier & Thomas R. Saving - 23-48 Access to Fast Food and Food Prices: Relationship with Fruit and Vegetable Consumption and Overweight among Adolescents
In: The Economics of Obesity
by Lisa M. Powell & M. Christopher Auld & Frank J. Chaloupka & Patrick M. O’Malley & Lloyd D. Johnston - 49-78 A Behavioral Model of Cyclical Dieting
In: The Economics of Obesity
by Steven M. Suranovic & Robert S. Goldfarb - 79-111 Effects of Title IX and Sports Participation on Girls’ Physical Activity and Weight
In: The Economics of Obesity
by Robert Kaestner & Xin Xu - 113-128 Obesity and Diabetes: The Roles that Prices and Policies Play
In: The Economics of Obesity
by Inas Rashad - 131-148 Advances in Bariatric Surgery for Obesity: Laparoscopic Surgery
In: The Economics of Obesity
by William E. Encinosa & Didem M. Bernard & Claudia A. Steiner - 149-183 One Pill Makes you Smaller: The Demand for Anti-Obesity Drugs
In: The Economics of Obesity
by John Cawley & John A. Rizzo - 187-217 Obesity, Employment and Wages in Europe
In: The Economics of Obesity
by Jaume Garcia & Climent Quintana-Domeque - 219-251 Obesity and Occupational Attainment among the 50+ of Europe
In: The Economics of Obesity
by Petter Lundborg & Kristian Bolin & Sören Höjgård & Björn Lindgren - 253-275 Gender, Body Mass, and Socioeconomic Status: New Evidence from the PSID
In: The Economics of Obesity
by Dalton Conley & Rebecca Glauber - 279-318 Health Insurance and the Obesity Externality
In: The Economics of Obesity
by Jay Bhattacharya & Neeraj Sood - 319-332 Obesity, Hospital Services use and Costs
In: The Economics of Obesity
by Nana Bro Folmann & Kristine Skovgaard Bossen & Ingrid Willaing & Jan Sørensen & John Sahl Andersen & Steen Ladelund & Torben Jørgensen - 333-364 How much does Obesity Matter? Results from the 2001 Canadian Community Health Survey
In: The Economics of Obesity
by William MacMinn & James McIntosh & Caroline Yung
2005
- 3-14 The Psychobiology of Aggressive Behaviour
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Lil Träskman-Bendz & Sofie Westling - 15-39 Individual Behaviours and Substance Use: The Role of Price
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Michael Grossman - 41-60 Demand for Illicit Drugs Among Pregnant Women
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Hope Corman & Kelly Noonan & Nancy E. Reichman & Dhaval Dave - 61-90 The effect of alcohol consumption on the earnings of older workers
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Henry Saffer & Dhaval Dave - 91-120 Drugs and Juvenile Crime: Evidence from a Panel of Siblings and Twins
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by H. Naci Mocan & Erdal Tekin - 121-141 Antidepressants and the suicide rate: is there really a connection?
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Matz Dahlberg & Douglas Lundin - 145-171 Choice, Social Interaction and Addiction: The Social Roots of Addictive Preferences
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Ole-Jørgen Skog - 173-199 The Spread of Drug Use: Epidemic Models or Social Interaction?
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Hans O. Melberg - 201-211 Structural Estimation of Peer Effects in Youth Smoking
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Brian Krauth - 215-228 Trends in Wine Consumption in Norway: Is Diffusion Theory Applicable?
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Ingeborg Rossow - 229-256 An Investigation of the Effects of Alcohol Policies on Youth Std
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Michael Grossman & Robert Kaestner & Sara Markowitz - 257-275 Can We Model the Impact of Increased Drug Treatment Expenditure on the U.K. Drug Market?
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Christine Godfrey & Steve Parrott & Gail Eaton & Anthony Culyer & Cynthia McDougall - 277-291 Tobacco Control Policies and Youth Smoking: Evidence from a New Era
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by John A. Tauras & Sara Markowitz & John Cawley - 293-312 The Fires are not out yet: Higher Taxes and Young Adult Smoking
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Philip DeCicca & Don Kenkel & Alan Mathios - 313-327 Coupons and Advertising in Markets for Addictive Goods: Do Cigarette Manufacturers React to Known Future Tax Increases?
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Dean R. Lillard & Andrew Sfekas - 331-346 Symbolism and Rationality in the Politics of Psychoactive Substances
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Robin Room - 347-369 What Does it Mean to Decriminalize Marijuana? A Cross-National Empirical Examination
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Rosalie L. Pacula & Robert MacCoun & Peter Reuter & Jamie Chriqui & Beau Kilmer & Katherine Harris & Letizia Paoli & Carsten Schäfer - 371-395 Economic Perspectives On Injecting Drug Use
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by David E. Bloom & Ajay Mahal & Brendan O’Flaherty - 397-429 Models Pertaining to How Drug Policy Should Vary Over the Course of a Drug Epidemic
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Jonathan P. Caulkins - 431-450 Economic Evaluation of Relapse Prevention for Substance Users: Treatment Settings and Health Care Policy
In: Substance Use: Individual Behaviour, Social Interactions, Markets and Politics
by Tetsuji Yamada & Chia-Ching Chen & Tadashi Yamada